Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1855 of 5804
-
New birth control patch could offer hormonal option without estrogen
Disease control OngoingThe Sponsor is developing a progestin-only contraceptive transdermal system (patch). The main purpose of this study is to look at how safe the study patch is and how well it works in preventing pregnancy. The study will also look at how well the study patch is tolerated. The st…
Phase: PHASE3 • Sponsor: Mylan Pharmaceuticals Inc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a light on the forehead ease autism symptoms?
Symptom relief Recruiting nowThe investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this …
Phase: NA • Sponsor: Francisco Gonzalez-Lima, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can nicotine pouches replace cigarettes? new study aims to find out
Knowledge-focused Recruiting nowThis clinical trial evaluates the characteristics of oral nicotine pouches (ONPs) to determine if they are a comparable substitute to cigarette or smokeless tobacco (ST) products. ONPs contain nicotine but no tobacco and are used primarily by adult tobacco uses in the United Stat…
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Pill vs. needle: can roflumilast regrow hair in alopecia areata?
Disease control CompletedEvaluation of the Efficacy and Safety of a drug called Oral Roflumilast versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata.
Phase: PHASE4 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 26, 2026 17:01 UTC
-
Listening for breaks: ultrasound may replace x-rays for hip fractures
Diagnosis CompletedHip (femoral neck and pertrochanteric) fractures account for a significant part of Emergency Department (ED) visits after trauma. Studies suggest that point-of-care ultrasound (POCUS) is a reliable diagnostic tool for fracture assessment. POCUS has several advantages over convent…
Phase: NA • Sponsor: Frisius Medisch Centrum • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
A smartphone nature challenge could boost teen social bonds
Symptom relief CompletedWe used a mixed-methods approach involving a RCT study followed by focus group discussions to obtain a more integrative understanding of the effects of a 10-week nature-noticing intervention.
Phase: NA • Sponsor: The Chinese University of Hong Kong, Shenzhen • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Simple tube after spine surgery may cut complications
Disease control Recruiting nowThis project is being done to understand if a drain reduces recovery problems after surgery, such as infection or the need for more surgery.
Phase: NA • Sponsor: Twin Cities Spine Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can diet help fight endometrial cancer? new study tests fasting vs balanced eating
Disease control Recruiting nowIn this study, overweight and obese patients with endometrial cancer treated with fertility- sparing therapy were randomly divided into three groups. The first group was given Intermittent fasting, the second was given Low-energy balanced diet, the third group underwent routine c…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could gilteritinib keep AML in remission longer after transplant?
Knowledge-focused CompletedPeople with acute myeloid leukemia (AML) are usually treated with chemotherapy. When the cancer comes back (relapse) the next treatment is usually a stem cell transplant. Some people with AML have a changed FLT3 gene which causes leukemia cells to grow faster. This means their ca…
Sponsor: Astellas Pharma Singapore Pte. Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:35 UTC
-
Firefighters' diet study shows promise for lowering cancer markers
Disease control CompletedInvestigators hope to learn about potential dietary intervention strategies (specifically a whole-food, plant-based diet) that may help lower cancer markers in firefighters.
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for aggressive brain cancer? early trial launches for recurrent glioblastoma
Disease control Recruiting nowThe clinical study of YSCH-01 will adopt an open-label, randomized design, with a planned enrollment of 10 participants with recurrent glioblastoma. Participants will be randomly allocated to the YSCH-01 monotherapy cohort or the YSCH-01 + Atezolizumab combination cohort, with 5 …
Phase: EARLY_PHASE1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New heart stent put to the test in 1,000 patients
Disease control Recruiting nowThe objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Which biopsy method best spots aggressive prostate cancer? major trial launches
Knowledge-focused Recruiting nowThis study is an international multicentre RCT to compare the linically significant prostate cancer (csPCa) detection of cognitive-guided and MRI-USG guided biopsies in men with suspicious MRI lesion.
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
AI predicts lung surgery pain, could cut opioid use
Knowledge-focused CompletedIntroduction Throughout human history, surgical interventions have been frequently used in human treatment. However, despite their therapeutic properties, the pain experienced by patients, especially in the acute postoperative period, can be quite challenging for clinicians. Acut…
Sponsor: Ankara Ataturk Sanatorium Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Blood test may spot ovarian cancer return before symptoms show
Knowledge-focused Recruiting nowThis is an interventional (category 2), prospective, multicentric cohort study designed to demonstrate that the search, based on Circulating tumour DNA analysis, for a BRCA1/2 reversion mutation leading to restoration of its protein function enables early identification of diseas…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Quick eye test may spot autism risk in toddlers
Diagnosis Recruiting nowThe study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Can abiraterone acetate improve outcomes for metastatic prostate cancer? a large Real-World study investigates
Disease control OngoingObjectives of Study: Primary Objective: To observe and evaluate the safety of abiraterone acetate tablets (II) and conventional abiraterone tablets in patients with metastatic prostate cancer under real-world conditions, including the types, incidence, and severity of treatment-r…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Old antibiotic, new trick: could minocycline tame resistant hypertension?
Disease control Recruiting nowThe goal of this clinical trial is to learn about the mechanisms by which minocycline effect blood pressure in individuals with treatment-resistant hypertension. The main questions it aims to answer are: * To what extent does minocycline lower blood pressure? * Are such blood pr…
Phase: PHASE4 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control Recruiting nowA phase Ⅰ clinical study evaluating the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of GEN-725 tablets in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Henan Genuine Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a magnetic helmet boost memory in Alzheimer's?
Symptom relief Recruiting nowAlzheimer's Disease (AD) is the primary cause of dementia, with its prominent feature being cognitive decline. The cerebellum plays a crucial role in cognitive processing, making it a potential target for therapeutic intervention. This study will be conducted to evaluate the effi…
Phase: NA • Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC